文献
J-GLOBAL ID:201702242013760547
整理番号:17A1217627
複合磁気腫瘍標的磁気共鳴イメージングと光化学療法のためのプログラムされた近赤外光応答性薬物送達システム【Powered by NICT】
Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy
著者 (20件):
Feng Qianhua
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Feng Qianhua
(Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001, China)
,
Feng Qianhua
(Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, Zhengzhou 450001, China)
,
Zhang Yuanyuan
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Zhang Wanxia
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Hao Yongwei
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Hao Yongwei
(Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001, China)
,
Hao Yongwei
(Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, Zhengzhou 450001, China)
,
Wang Yongchao
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Wang Yongchao
(Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001, China)
,
Wang Yongchao
(Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, Zhengzhou 450001, China)
,
Zhang Hongling
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Zhang Hongling
(Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001, China)
,
Zhang Hongling
(Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, Zhengzhou 450001, China)
,
Hou Lin
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Hou Lin
(Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001, China)
,
Hou Lin
(Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, Zhengzhou 450001, China)
,
Zhang Zhenzhong
(School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China)
,
Zhang Zhenzhong
(Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001, China)
,
Zhang Zhenzhong
(Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, Zhengzhou 450001, China)
資料名:
Acta Biomaterialia
(Acta Biomaterialia)
巻:
49
ページ:
402-413
発行年:
2017年
JST資料番号:
W3136A
ISSN:
1742-7061
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)